Jain Global’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,518
Closed -$5.13M 1830
2026
Q1
$5.13M Buy
+17,518
New +$5.76M 0.02% 484
2025
Q4
Sell
-13,072
Closed -$4.22M 1304
2025
Q3
$4.22M Buy
+13,072
New +$4.07M 0.02% 396
2025
Q2
Sell
-25,398
Closed -$11M 1303
2025
Q1
$11M Buy
25,398
+16,032
+171% +$6.44M 0.13% 121
2024
Q4
$3.46M Buy
+9,366
New +$3.92M 0.1% 172

Other funds holding ELV

Jain Global's ELV Position: Q2 2026 in Review

Jain Global sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 17,518 shares — an estimated $5.13M sold.

Jain Global first reported a position in ELV in Q4 2024 and held it in 4 quarters. The position peaked at $11M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Jain Global reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Jain Global sold 17,518 Elevance Health shares in Q2 2026, an estimated $5.13M.
  • Jain Global first reported a position in Elevance Health in Q4 2024 and held it in 4 quarters.
  • Jain Global's Elevance Health position peaked at $11M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.